 |
|
Professor Serigne Magueye Gueye
Serigne Gueye is a Professor of Urology at the University of Cheikh Anta Diop and Head of Urology at the Hopital General de Grand Yoff, in Dakar, Senegal.
Professor Gueye has received a number of honours, awards and fellowships. Among the medals received are:
- United Nations' Medal for Peace in Rwanda
- Ordre National du Mérite" of France
- "Croix de la valeur militaire avec étoile de Bronze", of France
- "Chevalier del ordre National du Lion du Senegal", Senegal
- "Ordre National du Tchad", Chad Republic
- "Officier del ordre National du Lion du Senegal", Senegal
Professor Gueye has published in numerous scientific journals and is an active member of several committees in his field of urology.
|
|
| |
Professor Isaac Adewole
Professor Isaac Adewole is currently Head, Department of Obstetrics & Gynaecology and a member of the Governing Council of the University of Ibadan, Nigeria. He undertook a research fellowship in the Department of Medical Oncology at Charring Cross Hospital in London (1985-86). He was Dean of the Faculty of Clinical Sciences & Dentistry (2000-2002), and Provost at the College of Medicine, University of Ibadan from 2002-2006.
Professor Adewole is Principal Investigator of the Harvard PEPFAR (APIN Plus) programme at the University College Hospital, Ibadan and Chairman of the PMTCT National Task Team Subcommittee on anti-retrovirals. He is also the country's Principal Investigator for ‘Operation Stop Cervical Cancer' in Nigeria. Secretary-General of the Confederation of African Medical Associations and Societies (CAMAS) from 1997-2003. Professor Adewole holds memberships of many learned societies, including the Nigerian Medical Association, the Society of Gynaecology & Obstetrics of Nigeria, International Federation of Gynecology and Obstetrics (FIGO), International AIDS Society (IAS), and the International Gynecological Cancer Society(IGCS) and the African Organisation for Research and Training In Cancer (AORTIC).
Professor Adewole's research interests include evaluating strategies for promoting cervical cancer prevention in developing countries, a multi-country study on HPV in cervical cancer among African women. He has published numerous articles in peer-reviewed journals and books on gynaecological oncology, abortion, HIV/AIDS and perinatal medicine. He is the Guttmacher Institute's 2008 Bixby Leadership Fellow in Reproductive health and the current chair of the sub-Saharan African Cervical Cancer Working Group (CCWG).
|
Dr Twalib Ngoma
Dr Twalib A. Ngoma is the Executive Director of the Ocean Road Cancer Institute in Dar es salaam, Tanzania. In this position he supervises the day-to-day running of the Institute and advises the Ministry of Health in Tanzania on Cancer Control Policies. He is also the head of the Tanzania office of the International Network for Cancer Treatment.
|
|
Professor Lynette Denny
Lynette Denny is a gynaecological oncologist working as a principal specialist and Professor in the Department of Obstetrics & Gynaecology at Groote Schuur Hospital/University of Cape Town. Her work includes clinical service, teaching and training and research. Her two main research interests have centred around prevention of cervical cancer in low resource settings and violence against women.
In the former, she has collaborated with researchers from Columbia University in New York in three large community-based cervical cancer screening projects located in informal housing settlements outside Cape Town since 1996. This work has been funded by Engender Health and the Bill & Melinda Gates Foundation. To date over 18 000 indigent women have been screened in this project, which has just completed a randomised trial of screening and treatment using visual inspection and HPV DNA testing as primary screening tests. She is currently conducting a randomised trial of the safety and immunogenicity of the bivalent HPV vaccine in HIV Positive women.
She was appointed Secretary Treasurer of AORTIC in 2003 and has held this position to date. She has organised two very successful conferences and is busy organising the third AORTIC international conference and has been instrumental in building up the infrastructure and capacity of the organisation.
Professor Denny has received a number of awards, including being the first recipient of the Shoprite Checkers/SABC 2 Woman of the Year award for Science and Technology in 2003. She has published in international peer reviewed journals and is a member of a number of international committees in her field of gynaecological oncology |
. |
Dr Anna Mary Nyakabau
Dr Anna Mary Nyakabau was born on 28 September 1960 in Nyanga , Zimbabwe . She is a mother of 3 children. In November 1985 she graduated as a doctor at Godfrey Huggins School of medicine with Honours in Biochemistry and pathology and was awarded the Harrison Wulf Prize in Obstetrics and Gynecology. From 1990 to 1993 she trained as an oncologist under the University of Zimbabwe and the WHO partnership interregional programme. In November 2003 she graduated with Masters in Medicine Radiotherapy and oncology and was awarded the degree with Honours. From 2004 to 2006 she studied for a Master of Philosophy in Palliative care degree with the University of Cape Town. She will graduate following submission of research work. She is studying for her Masters in Public Health with the University of Zimbabwe from 12 January 2009 .
Dr Nyakabau is currently employed by the Ministry of Health Zimbabwe as an oncologist. She is a part-time lecturer at the University of Zimbabwe and a part-time private oncologist in Zimbabwe and Malawi . She is a Board member of various organisations including Island Hospice, Cancer Association, Zimbabwe National Cancer Registry and Zimbabwe Brain Tumour Association. She is also an executive committee member of the Malawian Cancer Society. She is also the Chairperson of the Zimbabwe HPV Vaccine Advocacy Team.
She is involved in various public cancer education (live, radio and television) programmes in Zimbabwe and Malawi . She has presented at various clinical meetings in Zimbabwe and abroad.
|
|
 |
Professor Jean-Marie Kabongo Mpolesha
Professor Jean-Marie Kabongo Mpolesha was born in Mikalayi, Democratic Republic of Congo. He received his MD Diploma from the University of Zaire in 1976, Diploma in Pathology from the University of Kinshasha in 1994 and a PhD also from the University of Kinshasa in 2003.
He has published many articles in peer-reviewed journals and is a member of the Académie Internationale de Pathologie (AIP), Division Française et Division d'Afrique Francophone (DAF); Association Panafricaine des Pathologistes and the Association des Professeurs de l'Université de Kinshasa APUKIN).
|
Dr Kamal E H Mohamed
Kamal Eldein Hamed Mohamed, Dr FFRRCSI ( Dublin ),DMRT (Edinburgh), DSN( Vienna ).
Associate Professor of Oncology, Faculty of Medicine, University of Khartoum, Khartoum , SUDAN .
Senior Consultant of Oncology and Nuclear Medicine, the Radiation and Isotopes Centre of Khartoum , RICK.
Academic Secretary of the Postgraduate Board of Oncology at the Sudanese Medical Specialization Board.
Representative of Sudan in UNSCEAR IAEA.
Ex Nuclear Medicine IAEA Coordinator for Sudan .
Representative of Sudan in the Arab Association of Doctors Against Cancer, AMAAC.
Representative of Sudan in the European Arab School of Oncology Board, EASO.
Principal Investigator of the Sudan and European School of Oncology, ESO, Early Detection of Breast Cancer, Multicentre controlled Study.
Member of: ESMO, AORTIC, EORTIC, EASO, ESTRO & AMAAC
|
|
 |
Ms Chidinma Uwajumogu
Chidinma Uwajumogu, Executive Secretary of Ego Bekee Cancer Foundation, earned her B.A. (history) in 1984 and MSC (Political Science) with emphasis in international affairs, in 1990 from the University of Lagos in Nigeria and LLB (Hons) from the University of Hertfordshire in the UK in 2001, where she won the University prize for the best International student.
In 2006, Chidinma lost her mother to breast cancer and Ego Bekee Cancer Foundation was formed to create awareness for early detection and to give a voice to the underserved women, many of whom live in the rural areas and do not have access to medical facilities.
Chidinma has actively participated in many cancer control conferences and summits, notable among which are the UICC World Cancer Conference in Geneva in 2008 and the Livestrong Global Cancer Summit in August 24 th -26 th 2009 in Dublin, Ireland.
In 2007, the Foundation hosted a dinner for the delegates to mark the end of the ASCO/AORTIC Multidisciplinary workshop in Abuja.
In Nigeria, we collaborate with the Federal Ministry of Health, Breast Without Spots, Breast Awareness Initiatives and many other NGOS.
Her interest is to bridge the Cancer gap through Advocacy, Education and Screening. For an effective advocacy, Chidinma built a media Studio for the Foundation to produce documentaries being used as tools for Advocacy and Education in Schools, Religious places and Rural Communities in Nigeria.
Ego Bekee is at the forefront of pushing for legislation, a cancer bill that will make Screening and Treatment available and Free for all Nigerians.
Ego bekee cancer foundation participated actively in the launch of the international cancer center in Abuja by our first lady, Hajia Turai Yar'Adua.
My Vision is to make Communities in Nigeria a Cancer Conscious Public through our Radio Programme, “Cancer Today''
Chidinma is also a Member, Board of Trustees, of the Hospice and Palliative Care Association of Nigeria; CEO: Xcell Plus Limited, A Gym and Fitness Centre; CEO: Xcell Plus Communications Limited and Director: Eastern Comfort Hotels, Umuahia- Abia State.
|
Dr Anne Merriman
Dr Anne Merriman was born in Liverpool in 1935, Anne has spent 26 years in Africa and 7 years in SE Asia and only 8 years working in the UK.
After graduating at UCD, Ireland in 1963, she went to Nigeria as a Medical Missionary of Mary in 1964 and was there over a period of 10 years. During this time she was hands on in surgery, obstetrics, paediatrics and medicine.
After returning to the UK , she specialised in Geriatric Medicine and was a consultant from 1974 to 1981. She introduced palliative care into Singapore in 1984, when she undertook initial research into the needs of those dying from cancer, while Senior Teaching Fellow in the Department of Social and Preventative Medicine (now COFM) in National University of Singapore. This was followed up by meeting the needs with a volunteer group of doctors and nurses, who visited patients in their own home and introduced palliative care, using the analgesic ladder, to Singapore from 1985. Today this service is one of the best in SE Asia.
In 1990 she was invited to be the first Medical Director of Nairobi Hospice which opened in January 1990. After a publication in the journal CONTACT, published at the invitation of Dame Cicely Saunders, the editor, she received many letters from different African countries, asking her to assist their own people as the team were assisting in Nairobi . The inspiration to start a “model” affordable service for Africa started there.
In 1993, the “model” became a reality as Hospice Africa Uganda was commenced. This is now a success story in Uganda and a model for Africa and even the world as they are the first country to allow specially trained Nurses to prescribe oral morphine, as recommended in 1996 by WHO for countries where there are insufficient prescribers (doctors only) to bring pain control to those suffering severe pain from cancer or HIV/AIDS.
Anne is also a founder member of the Palliative Care Association of Uganda (1999) and the founding Vice-President. She is also a founder member of the African Palliative care Association and Vice Chair of the Board. She is a Board member of Hospice Africa UK and Hospice Africa Uganda. She is a Board Member of the International Association for Hospice and Palliative Care (IAHPC) since 2006.
Anne has published more than 90 articles, 5 books and is editor and a peer reviewer for several journals. She is presently sought as a speaker for several international conferences per year and still is involved with bringing affordable and culturally appropriate palliative care to other African countries.
|
|
 |
Dr Carrie Hunter
Carrie P. Hunter is President and CEO of Oncology Consulting International, a cancer care management, research,
education, and training consultancy company. She promotes collaborations and partnerships in cancer care,
prevention and treatment research that lead to a better understanding of factors that impact cancer outcomes.
She facilitates education and training initiatives for capacity building of the cancer health care workforces
in developing countries. Public health solutions to cancer health disparity and policy issues that affect
underserved populations in developed and developing countries are encouraged.
Dr. Hunter is a graduate of the New York University School of Medicine, with hematology and medical oncology training from
the Peter Bent Brigham Hospital and the Dana Farber Cancer Institute, Boston, MA. She is the Vice President for the North
America region (2007-2009) of the African Organization for Research and Training in Cancer, Inc. (AORTIC) and is a member
of the AORTIC Executive Committee and Council.
She served as chairperson of the AORTIC Scientific Program Committee for
the 2003 Accra, Ghana Conference on Cancer in Africa and facilitated the successful re-establishment of the AORTIC
organization in Africa. She is on the Board of Directors of the African Cancer Center, Inc. – a new center which is
planned for development in Lagos, Nigeria.
Dr. Hunter is a member of the 2007 Avon Foundation Scientific Advisory Board;
and she is on the Board of Governors of the New York University School of Medicine Alumni Association.
Dr. Hunter has served as a program director for the Community Clinical Oncology Program at the National Cancer Institute
and as a program director and project officer for the National Institutes of Health Women’s Health Initiative, Bethesda, MD, USA.
She is co-editor of a book on Cancer in the Elderly published in 2000 by Marcel Dekker, Inc., New York, and a second book on
Treatment and Management of Cancer in the Elderly published in 2006 by Taylor & Francis Group, New York.
|
Ms Petra Fordelmann
Current employment:
Director of Creative Wellness, Nursing agency with a focus on Cancer care
Previous employment:
Nursing service manager - iThemba LABS, Cape Town, South Africa
22 years of experience in Oncology, including Oncology Home based care, hospital care and Oncology nurse management.
Other
Lecturer: B Tech Oncology Nursing: Cape Peninsula University of Technology
ISNCC board member representing Africa
AORTIC (African organization for research and training in cancer) executive council member
|
|
| |
Dr Paul Ndom
Dr Ndom is a lecturer at the Faculty of Medicine and Biomedical Sciences (FMSB) and is Head of the Medical Oncology Service of Yaounde General Hospital. He is the Director of INCTR in Cameroon ( www.inctr.org ) and Permanent Secretary of the EURO-AFRICAN Congress of Oncology. He is also the assistant Permanent Secretary of the National Cancer Control Committee in Cameroon and the founding President of a Non-governmental Organisation called Chemotherapy Solidarity (SOCHIMIO) ( www. Sochimio.org)
Dr Ndom is a former President of AORTIC.
|
Dr Timothy R. Rebbeck
Timothy R. Rebbeck, PhD, is Professor of Epidemiology, CCEB Senior Scholar, Director of the Center for Genetics and Complex Traits, Director of the Center for Population Health and Health Disparities, Director of the Laboratory for Molecular Epidemiology, and Associate Director for Population Science in the Abramson Cancer Center. His research focuses on the genetic and molecular epidemiology of cancer. He has directed multiple molecular epidemiologic studies to identify and characterize genes that are candidates for involvement in cancer etiology, and to describe the relationship of allelic variation of these genes with biochemical or physiological traits, cancer occurrences, and cancer outcomes. These studies have been undertaken to obtain a better understanding of the relationship between genetic, demographic, biochemical, environmental, and physiological risk factors and cancer in human populations. Dr. Rebbeck's research uses a multidisciplinary approach that combines methods from epidemiology, statistics, molecular biology, and classical genetics.
|
|
| |
Professor Sulma I. Mohammed
Sulma Mohammed; DVM, MS, PhD. Dr. Mohammed earned her MS and PhD degrees from Cornell and Purdue University, USA, respectively. She is a dual citizen of Sudan and United States of America. Dr. Mohammed is Assistant Professor of Cancer Biology, Director of Purdue University Cancer Center Drug Discovery Shared Resource, and Adjunct Professor of Medical Microbiology at Indiana University School of Medicine. Dr. Mohammed was a Walther Cancer Institute fellow and American association for Cancer Research-Cancer Research Foundation of America- Prevention Research Fellow.
Dr. Mohammed has a well funded laboratory (1 million US Dollars) to conduct studies on breast and bladder cancer. One of her research projects focuses on identification of models to study ER-negative breast cancer development and progression in women, especially African-American and African women (the majority of African and African-American women develop ER-negative tumors at a young age). Up to now, no specific treatment regime is found to treat ER-negative tumors as their counterpart ER-positive tumors.
In addition, Dr. Mohammed is working to identify biomarkers for early detection of breast cancer metastasis using proteomic-based approaches. Lately, she developed an interest in cervical cancer in collaboration with oncologists from Nigeria and Emory University, US.
Dr. Mohammed has received a number of awards, including African American Institute award, African women leaders in science award, and many American Association for Cancer Research travel awards. She has published her research findings in reputable journals that include Cancer Research and Molecular Cancer Therapeutic journals. She is a member of the editorial board of the Cancer Chemoprevention journal.
|
| Professor Olufunmilayo Olopade
Dr. Olufunmilayo Falusi Olopade graduated with distinction from the College of Medicine, University of Ibadan, Nigeria,
in 1980. She subsequently did her house job at the University College Hospital Ibadan after which she proceeded to the
Nigerian Navy Hospital, Lagos for her National Youth Service Corps. She left for the United States of American soon
thereafter and studied Internal Medicine at the famous Cook County Hospital in Chicago, Illinois where she was named
Chief Resident in 1986. Upon completion of her Hematology/Oncology Fellowship training at the University of Chicago,
she was appointed to the faculty in 1991 in recognition of her brilliance and talent. In 1992, she was appointed the
Director of the Cancer Risk Clinic, and in 1998, she was appointed Director of the Fellowship Program in the Section
of Hematology/Oncology of the same institution. Dr Olopade is now the Director of the Center for Clinical Cancer
Genetics in the Department of Medicine and holds many other faculty, hospital, and administrative posts.
Dr Olopade received the "Phenomenal Woman Award" in recognition of her work within the African American community. She received the Heroes in Health care award from the Access Community Network in 2005. Also, as recently as
September 2005, Dr Olopade was awarded the prestigious McArthur Fellows program.
|
|
| Ms Barrie Adedeji
Barrie Adedeji is a Certified Public Accountant in private practice and Financial Controller/Treasurer of AORTIC in New York. She is also Executive Director of ENHICA International, Inc. and has developed and organized workshops and seminars that address health and environmental issues in Africa and the Caribbean. She was a member of the steering committee that organized the AORTIC conference in Accra, Ghana in 2003, and is a member of the fund raising committee for AORTIC in the United States. Barrie sits on the board of several health-related institutions and acts as mentor/advisor to professional women's groups in the international community. She has also served on the Budget and Finance Committee of New York's Riverside Church.
Ms. Adedeji attended New York University and completed her graduate work in Intercultural Service, Leadership and Management with concentrations in Sustainable Development and Conflict Transformation at The School for International Training in Vermont.
|
|
Professor Ahmed Elzawawy
Internationally and in Africa:
Council Member at Large and special representative for Egypt of AORTIC.
President of the International Campaign for Establishment and Development of Oncology Centers (ICEDOC) & ICEDOC's Experts in Cancer Without Borders . A non governmental organisation , registered in Texas, USA.
Co- President and Director of South and East Mediterranean College of Oncology (SEMCO).
Member on the Special panel, Advisory Board, International network for cancer treatment and research (INCTR) & Member of INCTR's Breast Cancer Strategy Group.
Locally in Egypt :
• Chairman & Professor of Clinical Oncology (Radiation and Medical Oncology) and Nuclear Medicine department, Faculty of Medicine, Suez Canal University Hospital, Ismailia, Egypt. I am a Professor of clinical oncology since 1992. Before that date I was Assistant Professor (1987), and Lecturer (1983-1987) in the same faculty of medicine, Suez Canal University. I therefore have more than 25 years experience in university education.
• Chairman and senior consultant of Al Soliman Radiation Oncology Centre (ASROC) Al Soliman Hospital, Port Said, Egypt (since its foundation in 1993, till present).
• Consultant and Supervisor of Cancer Chemotherapy Unit, Port Said General Hospital, Egypt. (Since 1983 till present).
I am also one of the six senior professors who are members of the Permanent Scientific Committee appointed by the Supreme council of Egyptian Universities and the decree of The of Minister of High Education in Egypt. This committee evaluates researchers, university teaching and clinical work of all candidates for the posts of professors and associate professors in Clinical Oncology, Surgical Oncology and related clinical disciplines in all the Egyptian Universities. |
|
| |
|
Dr Francis Ali-Osman
Dr. Ali-Osman, Associate Director of the Duke Comprehensive Cancer Center, is Professor (Department of Surgery) and holder of the Margaret Harris and David Silverman Distinguished Chair in Neuro-Oncology at the Duke University School of Medicine, Durham, North Carolina, USA. Born in Tamale, Ghana, Dr. Ali-Osman was educated at the University of Science and Technology, Kumasi (Ghana) and the Free University, Berlin, Germany, where, in 1982, he received the doctorate degree.
After early training in cancer research and hematology at the Free University, he joined the Brain Tumor Center, University of California, San Francisco. He has held Professorial positions at the University of Washington, Seattle and the University of Texas MD Anderson Cancer Center, where from 1990 to 2001, he was Chairman of the Department of Experimental Pediatrics. His many academic honors include Distinguished Professorships (University of Texas and Duke University) and the Hoshino Award (University of California). He has authored more than 120 scientific papers, edited two books and serves on the editorial boards of eleven major medical scientific journals and on the advisory boards of three major cancer foundations in the USA. He is an active member and has held several offices in the American Association for Cancer Research. |
|
|
|
|
|
